New insights into the biology of kidney cancer, including those informed ... underlying the disease has allowed for the rational development of therapies that have positively affected many ...

Our kidney cancer research has uncovered underlying causes of the disease, and has led to the development of new and better treatments and technologies that could treat it. An ICR team including ...

This deep understanding of kidney cancer biology has led to several ... science underlying the disease has allowed for the rational development of therapies that have positively affected many ...

Advances in Kidney Cancer Research and Care Aug. 28 ... can change the way we diagnose and treat kidney ... Progress in Development of a New High-Tech Kidney Disease Urine Test July 9, 2024 ...

It’s important for patients with renal clear cell (RCC) carcinoma — a common type of kidney cancer — to consider the challenges associated with receiving Fotivda (tivozanib). Fotivda is a vascular ...

NKT2152, a novel HIF2a inhibitor, demonstrates significant efficacy in patients with advanced clear cell renal cell carcinoma ...

Gut bacteria, also known as the microbiome, refers to the trillions of microscopic organisms that reside in ... potentially leading to the development of colon cancer. Scientists have been studying ...

A common drug used to treat kidney cancer could slash the risk of heart attacks, a study suggests. Cambridge University scientists found the anti-inflammatory medication, aldesleukin, reduced ...

Medical services at Bab al-Hawa hospital in northwest Syria are about to stop, and patients’ options are slim.

Nephron-sparing surgery may not reduce the risk for later kidney failure in patients with kidney cancer and stage 4 CKD. Despite the promise of nephron-sparing, new study findings suggest that the ...

TUESDAY, Sept. 17, 2024 (HealthDay News) -- A small clinical trial suggests that a duo of drugs can extend survival for people battling advanced kidney cancer. Researchers at Roswell Park Comprehe ...

New insights into the biology of kidney cancer, including those informed ... underlying the disease has allowed for the rational development of therapies that have positively affected many ...